1h Free Analyst Time
The antibody market is forecasted to grow by USD 8.95 billion during 2024-2029, accelerating at a CAGR of 8.3% during the forecast period. The report on the antibody market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and innovation in antibody engineering, expanding therapeutic applications and addressing high unmet medical needs, and rising prevalence of chronic diseases and a favorable regulatory environment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The antibody market is segmented as below:
By Type
- Monoclonal antibodies
- Polyclonal antibodies
- Others
By Therapeutic Area
- Oncology
- Autoimmune diseases
- Infectious diseases
- Cardiovascular diseases
- Others
By Application
- Therapeutic
- Diagnostic
- Research
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the antibody market covers the following areas:
- Antibody Market sizing
- Antibody Market forecast
- Antibody Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Type
8 Market Segmentation by Therapeutic Area
9 Market Segmentation by Application
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global antibody market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Cell Signaling Technology Inc., Celltrion Co. Ltd., Creative Biolabs, Danaher Corp., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Johnson and Johnson Services Inc., Leinco Technologies Inc., Merck and Co. Inc., Novartis AG, Novus Biologicals, Pfizer Inc., Proteintech Group, Regeneron Pharmaceuticals Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is ascendancy of next-generation antibody constructs."
According to the report, one of the major drivers for this market is the technological advancements and innovation in antibody engineering.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bio Rad Laboratories Inc.
- BioVendor Laboratorni medicina AS
- Cell Signaling Technology Inc.
- Celltrion Co. Ltd.
- Creative Biolabs
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- GenScript Biotech Corp.
- Johnson and Johnson Services Inc.
- Leinco Technologies Inc.
- Merck and Co. Inc.
- Novartis AG
- Novus Biologicals
- Pfizer Inc.
- Proteintech Group
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Sino Biological Inc.
- Thermo Fisher Scientific Inc.
